Zynerba Pharmaceuticals I...

NASDAQ: ZYNE · Real-Time Price · USD
1.30
0.03 (2.36%)
At close: Oct 10, 2023, 10:00 PM

Zynerba Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
50.64M 67.81M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
n/a n/a
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
4.13M 12.41M
Total Current Assets
54.78M 80.22M
Property-Plant & Equipment
745.79K 951.65K
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
745.79K 951.65K
Total Assets
55.52M 81.17M
Account Payables
1.94M 1.8M
Deferred Revenue
n/a n/a
Short-Term Debt
214.9K 209.07K
Other Current Liabilities
7.01M 7.9M
Total Current Liabilities
9.17M 9.9M
Long-Term Debt
119.52K 353.69K
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
119.52K 353.69K
Total Liabilities
9.29M 10.26M
Total Debt
334.43K 562.76K
Common Stock
47.9K 41.22K
Retained Earnings
-274.52M -239.48M
Comprehensive Income
n/a n/a
Shareholders Equity
46.23M 70.91M
Total Investments
n/a n/a